Lupin enters into marketing alliance with Forest Laboratories

News Flash

Key clients confidence is shaken in Satyam
Satyam could become vulnerable for acquisition
Satyam could face pricing pressure due to the situation
100 people a diminutive no.; not indicative of anything
Software, BPO staff among those planning to quit: Srcs
Resignations seen in lower, mid level management: Srcs
100 more may resign; to wait for board meet on 10th: Srcs
120 employees resign post Maytas fiasco: Sources
Senior mgmt unhappy with board decisions: Sources
To consider acquisition of housing finance co on Jan 8
Punj Lloyd wins order worth Rs 264cr for Sikkim Airport
Q2 Net Sales at Rs. 214.79cr vs Rs.162.71cr (QoQ)
Q2 PAT at Rs.31.03cr vs Rs.15cr (QoQ)
Nod for Gabapentin capsule from Health Canada
Expect Wipro to miss guidance in Q3
50% weight of Index under stress for Q3 earnings
Sensex FY'09 EPS may fall to Rs.880/sh post Q3 nos
HCL Tech had deferred Oct joining dates to Jan: NW
Defers joining date of some recruits by 3 months: NW
Magnitude of global eco slowdown to determine markets
Expect global markets to 'pick up' by end 2009
Neighbouring countries give sanctuaries to insurgents
Security situation has become more complex
Weak Q3 nos reflecting in the current stock prices
Trends for CY'09 hints at low inflation and interest rates
Expect GDP growth rate for current fiscal at 7%
Shanghai up 1.5%, Kospi up 1%, Taiwan up 0.5%
Hang Seng down 1.1%, Straits down 1%
Asian markets trade mixed; Nikkei up 0.5%
Sensex support seen at 10,180-9,980 levels

Updated: 19/08/2008 | 12:00 AM IST

Manufacturing

Capital Market

Tuesday, August 19, 2008 (New Delhi)

Blog

Comments:

Read (0)

Post

Rate the story

For AeroChamber Plus brand in US

Lupin has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus line of products with Forest Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals, Inc, USA, will use its 50 person sales force to promote the product to pediatricians.

AeroChamber Plus is a Valved Holding Chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and COPD. Aerochamber Plus also reduces the deposition of medication in the mouth and throat and makes metered dose inhalers easier for patients to use by reducing the need to coordinate actuation of the inhaler with inhalation. AeroChamber Plus is the most widely prescribed holding chamber in the United States and has been used by millions of patients since its introduction. Approximately two thirds of AeroChamber Plus Valved Holding Chamber prescriptions are written by pediatricians.

The company made this announcement during the trading hours today, 19 August 2008.